Daily Recap
Mike Tyson and Weldon Angelos, both of whose lives have been deeply impacted by cannabis, are encouraged by President Trump’s recent statements supporting long-overdue reforms to U.S. cannabis policy.
His commitments to reschedule cannabis, ensure banking access for businesses, and grant clemency to individuals serving federal sentences for cannabis offenses reflects a bold vision for justice and economic opportunity, they offer.
Trump has proven that he can deliver. Weldon Angelos worked with his administration on the First Step Act and clemency initiatives, culminating in a full presidential pardon by Trump in 2020 after serving 13 years of a draconian 55-year sentence for cannabis.
Tyson has known Trump for decades and can attest that “Trump is a man of his word” and, from personal experience, both know that Trump will take bold, compassionate action for the economy, for justice and for the thousands of families that remain torn apart by outdated cannabis laws, and who were left to rot in prison by Joe Biden.
Blast from the Past
The DEA has a new interim leader and he’s no canna fan. Derek Maltz Sr. previously linked cannabis usage to school shootings and insisted Biden hijacked rescheduling for political purposes.
As President Trump has yet to name his choice for DEA administrator, it’s unclear if Maltz will remain in the position or if he’ll be replaced. Mr. Maltz is a bit of a legend in DEA circles as he was a major player in the capture of Joaquín "El Chapo" Guzmán.
I’ve known the Maltz clan for over a decade, having mentored his eldest son after he graduated Syracuse and having stayed close as his brothers, like dad, won a natty in college lacrosse (Maryland). Truth be told, they’re one of the finer families I know.
If Mr. Maltz remains in that role, let’s hope he will continue to focus his energies on dismantling the cartels and making fentanyl Public Enemy #1, and that he honors the wishes of our President, who’s made his cannabis directive public knowledge.
"If there's scientific evidence to support [cannabis rescheduling], then so be it. But you've got to let the scientists evaluate it.” Derek Maltz, Acting DEA Admin
Confirmation Bias
Sen. Elizabeth Warren (D-MA) is pressing Robert F. Kennedy Jr.—President Donald Trump’s choice to lead the nation’s top health agency—to reiterate his position on marijuana legalization amid the ongoing effort to federally reschedule cannabis.
Kennedy has said multiple times he backs legalizing cannabis and certain psychedelic substances but as RFK Jr. prepares to potentially lead the U.S. Department of Health and Human Services, Warren wants to get those positions on the record.
AG nominee Pam Bondi was asked during her confirmation (via a written question) if she supports Trump’s canna stance, to which she responded, “If confirmed, I’ll give the matter careful consideration after consulting with appropriate Department officials.”
Mo Better Blues
Philip Morris International, the largest tobacco company in the world by market cap, is further extending its reach into cannabis through its subsidiary, Vectura Fertin Pharma.
The company announced a partnership with Avicanna, a Canadian biopharmaceutical firm specializing in cannabinoid-based medicine. The collaboration aims to advance medical cannabis research and accessibility in Canada as PMI continues its measured pivot toward health and wellness.
Stocks & Stuff
It was another thin session in Cannaland and the mirror image of the 2020 blue sweep continues to play through. Then, canna stocks rallied sharply into February before a four-year bear market emerged on the back of the do-nothing Dems. This time, there has been a steady melt since the red sweep as expectations of federal reform fade.
U.S. cannabis ETF MSOS finished the session -4% to notch a fresh all-time closing low.
Below, we’ll top-line the latest, chew through the headwinds and crosscurrents, get an update from Trulieve, check in on Pennsylvania and ease into the first week of DJT 2.0.
All that and more, just scroll down.
SPY 0.00%↑ QQQ 0.00%↑ IWM 0.00%↑ MSOS 0.00%↑ ETF Notional: $12M
Top Stories
Keep reading with a 7-day free trial
Subscribe to Cannabis Confidential to keep reading this post and get 7 days of free access to the full post archives.